Evidence map›Paper›PMID 28306633›Full record

ArticleJournal of hypertension2017

Race and sex differences in cardiovascular α-adrenergic and β-adrenergic receptor responsiveness in men and women with high blood pressure.

Andrew Sherwood, LaBarron K Hill, James A Blumenthal, Kristy S Johnson, Alan L Hinderliter

Open access · greenAbstract read
In one paragraph

Article in Journal of hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Race and sex differences in cardiovascular autonomic regulation.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2020
    Review
  16. Article
  17. Article
  18. Racial disparities in cardiovascular disease risk: mechanisms of vascular dysfunction.American journal of physiology. Heart and circulatory physiology · 2019
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Andrew SherwoodaDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham bDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
LaBarron K Hill
James A Blumenthal
Kristy S Johnson
Alan L Hinderliter
Duke Medical Center · USDuke University · USUniversity of North Carolina at Chapel Hill · US

Funding

Depression and Heart Failure Disease ProgressionR01HL121708 · NHLBI · DUKE UNIVERSITY · PI SHERWOOD, ANDREW · 2014 to 2018
$4.2M
BIOBEHAVIORAL MECHANISMS OF BLOOD PRESSURE REGULATIONR01HL049427 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SHERWOOD, ANDREW · 1993 to 1997
–
NHLBI NIH HHS R01 HL049427NHLBI NIH HHS R01 HL121708NIMHD NIH HHS L60 MD009947
6 · The paper itself

Abstract

objectiveHypertension is associated with unfavorable changes in adrenergic receptor responsiveness, but the relationship of race and sex to adrenergic receptor responsiveness in the development of cardiovascular disease is unclear. This study examined α-adrenergic and ß-adrenergic receptor responsiveness in African-American and white men and women with untreated high blood pressure (BP) (HBP) and with normal BP. METHODS AND

resultsThe study sample comprised 161 African-American and white men and women in the age range 25-45 years. Isoproterenol, a nonselective ß-adrenergic receptor agonist, was administered intravenously to determine the bolus dose required to increase heart rate by 25 bpm, an index of β-adrenergic receptor responsiveness. Similarly, phenylephrine, an α1-adrenergic receptor agonist, was administered to determine the bolus dose required to increase BP by 25 mmHg, an index of vascular α1-adrenergic receptor responsiveness. HBP (P < 0.01), male sex (P = 0.04), and higher BMI (P < 0.01) were all associated with reduced β-adrenergic receptor responsiveness, with a similar trend observed for African-American race (P = 0.07). Conversely, α1-adrenergic receptor responsiveness was increased in association with HBP (P < 0.01), female sex (P < 0.01), and African-American race (P < 0.01).

conclusionIn the early stages of hypertension, cardiovascular β-adrenergic receptors demonstrate blunted responsiveness, whereas conversely α1-adrenergic receptors exhibit increased responsiveness. This pattern of receptor changes is especially evident in men and African-Americans, is exacerbated by obesity, and may contribute to the development of cardiovascular disease.

Indexed as

Adrenergic alpha-1 Receptor AgonistsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AgonistsAdultBlack or African AmericanBlood PressureBody Mass IndexFemaleHeart RateHumansHypertensionIsoproterenolMaleMiddle AgedNorepinephrinePhenylephrineAdrenergic alpha-1 Receptor AgonistsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-AgonistsIsoproterenolNorepinephrinePhenylephrineReceptors, Adrenergic, alpha-1Receptors, Adrenergic, beta

Identifiers

PMID28306633
PMCPMC5785915
OpenAlexW2595149376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.